Cytokinetics Inc

CYTK
65,27
0,93 (1,45%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/4/202422:00GLOBECytokinetics to Host Investor Event and Conference Call to..
24/4/202422:00GLOBECytokinetics to Announce First Quarter Results on May 8,..
10/4/202413:30GLOBECytokinetics Announces Three Late Breaking Clinical Trial..
05/4/202413:30GLOBECytokinetics Presents Additional 48-Week Data From..
02/4/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
01/4/202422:00GLOBECytokinetics to Participate in the 23rd Annual Needham..
25/3/202413:15GLOBECytokinetics Announces Four Upcoming Presentations at the..
07/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:21EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:00GLOBECytokinetics to Participate in March Investor Conferences
02/3/202400:47PRNUSSuper Micro Computer and Deckers Outdoor Set to Join S&P..
01/3/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/2/202413:30GLOBECytokinetics Joins Global Initiative to Recognize..
28/2/202413:30GLOBECytokinetics, The Mended Hearts, Inc. and WomenHeart..
27/2/202422:05EDGAR2Form 8-K - Current report
27/2/202422:00GLOBECytokinetics Reports Fourth Quarter 2023 Financial Results
14/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:03EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:11EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:00GLOBECytokinetics to Announce Fourth Quarter Results on February..
06/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:10EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:00GLOBECytokinetics to Participate in the Oppenheimer 34th Annual..
02/2/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:38EDGAR2Form 8-K - Current report
31/1/202422:02EDGAR2Form 144 - Report of proposed sale of securities
29/1/202413:30GLOBECytokinetics Announces Recipients of Its Sixth Annual..
25/1/202413:30GLOBECytokinetics Presents New Data at CMR 2024 From FOREST-HCM, ..
22/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:49EDGAR2Form 144 - Report of proposed sale of securities
18/1/202419:00GLOBECytokinetics Announces New Data From FOREST-HCM to be..
12/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:09EDGAR2Form 144 - Report of proposed sale of securities
12/1/202412:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
11/1/202419:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
08/1/202419:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
04/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:02EDGAR2Form 144 - Report of proposed sale of securities
03/1/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 66,08 Min: 65,00 Max: 66,605
Chiusura: 64,34

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network